Uchiyama Holdings Co., Ltd. (6059) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor Management Efficiency with a low ROCE of 1.06%

The company has been able to generate a Return on Capital Employed (avg) of 1.06% signifying low profitability per unit of total capital (equity and debt)

Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.23 times

Poor long term growth as Net Sales has grown by an annual rate of -0.80% and Operating profit at -27.98% over the last 5 years

Flat results in Jun 25

With ROE of 16.36%, it has a very attractive valuation with a 0.47 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

JPY 7,177 Million (Micro Cap)

P/E

3.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.12

Return on Equity

17.27%

Price to Book

0.50

Revenue and Profits:

Net Sales:

7,333 Million

(Quarterly Results - Jun 2025)

Net Profit:

191 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

7.58%

6 Months

15.64%

1 Year

13.42%

2 Years

1.43%

3 Years

27.24%

4 Years

17.16%

5 Years

17.55%

Uchiyama Holdings Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-0.80%

EBIT Growth (5y)

-27.98%

EBIT to Interest (avg)

-5.70

Debt to EBITDA (avg)

5.23

Net Debt to Equity (avg)

0.07

Sales to Capital Employed (avg)

1.10

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

9.45%

Pledged Shares

Institutional Holding

ROCE (avg)

1.06%

ROE (avg)

4.27%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.47

EV to EBIT

36.63

EV to EBITDA

9.81

EV to Capital Employed

0.50

EV to Sales

0.26

PEG Ratio

0.01

Dividend Yield

ROCE (Latest)

1.37%

ROE (Latest)

16.36%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 1.83% vs 1.83% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 375.62% vs -60.55% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,333.20",
          "val2": "7,201.40",
          "chgp": "1.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "659.80",
          "val2": "230.80",
          "chgp": "185.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "42.90",
          "val2": "22.10",
          "chgp": "94.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "191.20",
          "val2": "40.20",
          "chgp": "375.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.00%",
          "val2": "10.30%",
          "chgp": "2.17%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 0.91% vs 7.18% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 859.00% vs 153.39% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "29,105.90",
          "val2": "28,842.90",
          "chgp": "0.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "778.70",
          "val2": "1,234.70",
          "chgp": "-36.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "113.90",
          "val2": "60.20",
          "chgp": "89.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-261.60",
          "val2": "-478.70",
          "chgp": "45.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,051.30",
          "val2": "213.90",
          "chgp": "859.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.20%",
          "val2": "20.40%",
          "chgp": "-1.32%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

7,333.20

7,201.40

1.83%

Operating Profit (PBDIT) excl Other Income

659.80

230.80

185.88%

Interest

42.90

22.10

94.12%

Exceptional Items

0.00

Consolidate Net Profit

191.20

40.20

375.62%

Operating Profit Margin (Excl OI)

32.00%

10.30%

2.17%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 1.83% vs 1.83% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 375.62% vs -60.55% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

29,105.90

28,842.90

0.91%

Operating Profit (PBDIT) excl Other Income

778.70

1,234.70

-36.93%

Interest

113.90

60.20

89.20%

Exceptional Items

-261.60

-478.70

45.35%

Consolidate Net Profit

2,051.30

213.90

859.00%

Operating Profit Margin (Excl OI)

7.20%

20.40%

-1.32%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 0.91% vs 7.18% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 859.00% vs 153.39% in Mar 2024

All Annual Results

Company CV

About Uchiyama Holdings Co., Ltd.

Uchiyama Holdings Co., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available